Asahi Kasei Secures FDA Approval for New Oral Antiviral TherapyAsahi Kasei gains FDA approval for a breakthrough oral antiviral, offering a new oral treatment for resistant herpes lesions in immunocompromised patients.ASAHI KASEI CORP Materials AI generated 12/11/2026, 14:44 2 minutes to read